192 related articles for article (PubMed ID: 29172434)
1. Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases.
Büttner D; Kramer JS; Klingler FM; Wittmann SK; Hartmann MR; Kurz CG; Kohnhäuser D; Weizel L; Brüggerhoff A; Frank D; Steinhilber D; Wichelhaus TA; Pogoryelov D; Proschak E
ACS Infect Dis; 2018 Mar; 4(3):360-372. PubMed ID: 29172434
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.
Arjomandi OK; Hussein WM; Vella P; Yusof Y; Sidjabat HE; Schenk G; McGeary RP
Eur J Med Chem; 2016 May; 114():318-27. PubMed ID: 27017264
[TBL] [Abstract][Full Text] [Related]
3. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem.
Tehrani KHME; Martin NI
ACS Infect Dis; 2017 Oct; 3(10):711-717. PubMed ID: 28820574
[TBL] [Abstract][Full Text] [Related]
4. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the discovery of metallo-β-lactamase inhibitors for β-lactam antibiotic-resistant reversing agents.
Guo Z; Ma S
Curr Drug Targets; 2014; 15(7):689-702. PubMed ID: 24666360
[TBL] [Abstract][Full Text] [Related]
6. Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors.
Rotter MJ; Zentgraf S; Weizel L; Frank D; Burgers LD; Brunst S; Fürst R; Proschak A; Wichelhaus TA; Proschak E
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838971
[TBL] [Abstract][Full Text] [Related]
7. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases.
Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J
Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and enzyme-based evaluation of analogues
Khalili Arjomandi O; Kavoosi M; Adibi H
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1414-1425. PubMed ID: 31401901
[TBL] [Abstract][Full Text] [Related]
9. 4-Amino-2-Sulfanylbenzoic Acid as a Potent Subclass B3 Metallo-β-Lactamase-Specific Inhibitor Applicable for Distinguishing Metallo-β-Lactamase Subclasses.
Wachino JI; Kanechi R; Nishino E; Mochizuki M; Jin W; Kimura K; Kurosaki H; Arakawa Y
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405855
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.
Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI
ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956
[TBL] [Abstract][Full Text] [Related]
11. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
12. Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.
Christopeit T; Leiros HK
Bioorg Med Chem Lett; 2016 Apr; 26(8):1973-7. PubMed ID: 26976213
[TBL] [Abstract][Full Text] [Related]
13. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
[TBL] [Abstract][Full Text] [Related]
14. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
Gavara L; Sevaille L; De Luca F; Mercuri P; Bebrone C; Feller G; Legru A; Cerboni G; Tanfoni S; Baud D; Cutolo G; Bestgen B; Chelini G; Verdirosa F; Sannio F; Pozzi C; Benvenuti M; Kwapien K; Fischer M; Becker K; Frère JM; Mangani S; Gresh N; Berthomieu D; Galleni M; Docquier JD; Hernandez JF
Eur J Med Chem; 2020 Dec; 208():112720. PubMed ID: 32937203
[TBL] [Abstract][Full Text] [Related]
15. Complete ¹H, ¹⁵N, and ¹³C resonance assignments of Bacillus cereus metallo-β-lactamase and its complex with the inhibitor R-thiomandelic acid.
Karsisiotis AI; Damblon C; Roberts GC
Biomol NMR Assign; 2014 Oct; 8(2):313-8. PubMed ID: 23838816
[TBL] [Abstract][Full Text] [Related]
16. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of (2-mercaptoacetyl)-L-[2-
Shirvani G; Shockravi A; Amini M; Saemian N
J Labelled Comp Radiopharm; 2017 Feb; 60(2):130-134. PubMed ID: 27943428
[TBL] [Abstract][Full Text] [Related]
19. Thiomandelic acid, a broad spectrum inhibitor of zinc beta-lactamases: kinetic and spectroscopic studies.
Mollard C; Moali C; Papamicael C; Damblon C; Vessilier S; Amicosante G; Schofield CJ; Galleni M; Frere JM; Roberts GC
J Biol Chem; 2001 Nov; 276(48):45015-23. PubMed ID: 11564740
[TBL] [Abstract][Full Text] [Related]
20. Approaches for the discovery of metallo-β-lactamase inhibitors: A review.
Shi C; Chen J; Kang X; Shen X; Lao X; Zheng H
Chem Biol Drug Des; 2019 Aug; 94(2):1427-1440. PubMed ID: 30925023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
